Use App
Trending
News
Earnings
All
DIA
0.75%
SPY
1.01%
QQQ
1.74%
Trending
SPY
1.01%
DJT
3.46%
NFLX
0.45%
AG
5.10%
SCO
5.78%
SPCL
56.56%
KLAC
2.46%
GLXY
6.12%
SOXL
11.95%
USO
3.81%
SPY
1.01%
DJT
3.46%
NFLX
0.45%
AG
5.10%
SCO
5.78%
SPCL
56.56%
KLAC
2.46%
GLXY
6.12%
SOXL
11.95%
USO
3.81%
home
Symbol
LLYX
news
LLYX
Defiance Daily Target 2X Long LLY ETF
$25.37
$1.26
(4.80%)
Today
·
Closed $24.99
$0.38
(1.52%)
Overnight
Updated:
08:23 PM EDT
1
2
5
1
2
5
Vol
341,169.00
52W High
$28.44
52W Low
$9.60
Full Chart
Fundamentals
Volume
-
52W High
$28.44
52W Low
$9.60
Avg. Volume
558,150.49
Feed
News
Sentiment
Fundamentals
Info
News
all
press releases
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Fourth-quarter revenue surged 43% to $19.3 billion, above Street estimates of $17.86 billion, according to Fiscal.ai data.
Stocktwits
Full Article
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
Full Article
<
...
1
>
Advertisement
|
Remove ads.
Latest LLYX News
View
LLY Stock Surges On Q4 Beat – Obesity, Diabetes Drugs Drive Strong FY26 Outlook
Stocktwits
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
Stocktwits
Loading...
Advertisement
|
Remove ads.
Advertisement
|
Remove ads.
Watchlist
Trending
News
Explore
Community
Profile